Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1977 1
1979 1
1983 1
1985 1
1987 4
1988 2
1989 5
1990 2
1991 5
1992 6
1993 6
1994 11
1995 2
1996 2
1997 6
1998 8
1999 9
2000 11
2001 13
2002 14
2003 14
2004 12
2005 15
2006 15
2007 9
2008 16
2009 22
2010 13
2011 27
2012 16
2013 25
2014 17
2015 14
2016 6
2017 4
2018 9
2019 12
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

341 results
Results by year
Filters applied: . Clear all
Page 1
Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
Zhanel GG, Lawrence CK, Adam H, Schweizer F, Zelenitsky S, Zhanel M, Lagacé-Wiens PRS, Walkty A, Denisuik A, Golden A, Gin AS, Hoban DJ, Lynch JP 3rd, Karlowsky JA. Zhanel GG, et al. Among authors: Hoban DJ. Drugs. 2018 Jan;78(1):65-98. doi: 10.1007/s40265-017-0851-9. Drugs. 2018. PMID: 29230684 Review.
Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.
Zhanel GG, Cheung D, Adam H, Zelenitsky S, Golden A, Schweizer F, Gorityala B, Lagacé-Wiens PR, Walkty A, Gin AS, Hoban DJ, Karlowsky JA. Zhanel GG, et al. Among authors: Hoban DJ. Drugs. 2016 Apr;76(5):567-88. doi: 10.1007/s40265-016-0545-8. Drugs. 2016. PMID: 26863149 Review.
Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli.
Zhanel GG, Chung P, Adam H, Zelenitsky S, Denisuik A, Schweizer F, Lagacé-Wiens PR, Rubinstein E, Gin AS, Walkty A, Hoban DJ, Lynch JP 3rd, Karlowsky JA. Zhanel GG, et al. Among authors: Hoban DJ. Drugs. 2014 Jan;74(1):31-51. doi: 10.1007/s40265-013-0168-2. Drugs. 2014. PMID: 24352909 Review.
Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination.
Zhanel GG, Lawson CD, Adam H, Schweizer F, Zelenitsky S, Lagacé-Wiens PR, Denisuik A, Rubinstein E, Gin AS, Hoban DJ, Lynch JP 3rd, Karlowsky JA. Zhanel GG, et al. Among authors: Hoban DJ. Drugs. 2013 Feb;73(2):159-77. doi: 10.1007/s40265-013-0013-7. Drugs. 2013. PMID: 23371303 Review.
Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-16 study.
McCracken MG, Adam HJ, Blondeau JM, Walkty AJ, Karlowsky JA, Hoban DJ, Zhanel GG, Mulvey MR; Canadian Antimicrobial Resistance Alliance (CARA) and CANWARD. McCracken MG, et al. Among authors: Hoban DJ. J Antimicrob Chemother. 2019 Aug 1;74(Supplement_4):iv32-iv38. doi: 10.1093/jac/dkz285. J Antimicrob Chemother. 2019. PMID: 31505643
Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin.
Zhanel GG, Lawson CD, Zelenitsky S, Findlay B, Schweizer F, Adam H, Walkty A, Rubinstein E, Gin AS, Hoban DJ, Lynch JP, Karlowsky JA. Zhanel GG, et al. Among authors: Hoban DJ. Expert Rev Anti Infect Ther. 2012 Apr;10(4):459-73. doi: 10.1586/eri.12.25. Expert Rev Anti Infect Ther. 2012. PMID: 22512755 Review.
Characterization of MRSA in Canada from 2007 to 2016.
Nichol KA, Adam HJ, Golding GR, Lagacé-Wiens PRS, Karlowsky JA, Hoban DJ, Zhanel GG; Canadian Antimicrobial Resistance Alliance (CARA) and CANWARD. Nichol KA, et al. Among authors: Hoban DJ. J Antimicrob Chemother. 2019 Aug 1;74(Supplement_4):iv55-iv63. doi: 10.1093/jac/dkz288. J Antimicrob Chemother. 2019. PMID: 31505646
Trends in antimicrobial resistance over 10 years among key bacterial pathogens from Canadian hospitals: results of the CANWARD study 2007-16.
Lagacé-Wiens PRS, Adam HJ, Poutanen S, Baxter MR, Denisuik AJ, Golden AR, Nichol KA, Walkty A, Karlowsky JA, Mulvey MR, Golding G, Hoban DJ, Zhanel GG; Canadian Antimicrobial Resistance Alliance (CARA) and CANWARD. Lagacé-Wiens PRS, et al. Among authors: Hoban DJ. J Antimicrob Chemother. 2019 Aug 1;74(Supplement_4):iv22-iv31. doi: 10.1093/jac/dkz284. J Antimicrob Chemother. 2019. PMID: 31505648
42936 pathogens from Canadian hospitals: 10 years of results (2007-16) from the CANWARD surveillance study.
Zhanel GG, Adam HJ, Baxter MR, Fuller J, Nichol KA, Denisuik AJ, Golden AR, Hink R, Lagacé-Wiens PRS, Walkty A, Mulvey MR, Schweizer F, Bay D, Hoban DJ, Karlowsky JA; Canadian Antimicrobial Resistance Alliance (CARA) and CANWARD. Zhanel GG, et al. Among authors: Hoban DJ. J Antimicrob Chemother. 2019 Aug 1;74(Supplement_4):iv5-iv21. doi: 10.1093/jac/dkz283. J Antimicrob Chemother. 2019. PMID: 31505641
Comparison of antimicrobial resistance patterns in Streptococcus pneumoniae from respiratory and blood cultures in Canadian hospitals from 2007-16.
Golden AR, Baxter MR, Davidson RJ, Martin I, Demczuk W, Mulvey MR, Karlowsky JA, Hoban DJ, Zhanel GG, Adam HJ; Canadian Antimicrobial Resistance Alliance (CARA) and CANWARD. Golden AR, et al. Among authors: Hoban DJ. J Antimicrob Chemother. 2019 Aug 1;74(Supplement_4):iv39-iv47. doi: 10.1093/jac/dkz286. J Antimicrob Chemother. 2019. PMID: 31505644
341 results
Jump to page
Feedback